Pharmacists' Workflow in Dosing and Monitoring Vancomycin

Overview

About this study

The purpose of this study is to define the current workflow of vancomycin management for the patient.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Pharmacists, residents, fellows, and attending physicians participating in the study will require verbal consent.

Exclusion Criteria:

  • Pharmacists, residents, fellows, and attending physicians not willing to verbally consent.

Eligibility last updated 8/4/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Kianoush Banaei Kashani, M.D., M.S.

Open for enrollment

Contact information:

Kianoush Banaei Kashani M.D., M.S.

(507) 538-7293

Kashani.Kianoush@mayo.edu

More information

Publications

Publications are currently not available